Back to Agenda
Session 1: Drug Development: An Overview
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Regulation Highlights
- Key Definitions
- Drug Development Highlights
- Regulatory Strategy
Have an account?